![An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/3235a9bf-f499-46dd-a7c9-32a4375a5d09/bcp13717-fig-0001-m.jpg)
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Promacta® Oral Suspension Recalled for Possible Peanut Contamination | Asthma and Allergy Foundation of America Promacta® Oral Suspension Recalled for Possible Peanut Contamination | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/518388543130060320/primaryPicture/true/fodoid/518388543130149971/imageType/LARGE/inlineImage/true/medicine-recall-alert-Novatris-Promacta.png)
Promacta® Oral Suspension Recalled for Possible Peanut Contamination | Asthma and Allergy Foundation of America
![These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA (eltrombopag) tablets, for oral usePROMACTA (eltrombopag) for oral suspensionInitial U.S. Approval: These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA (eltrombopag) tablets, for oral usePROMACTA (eltrombopag) for oral suspensionInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=promacta-spl-graphic-04.jpg&archiveid=238065)
These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA (eltrombopag) tablets, for oral usePROMACTA (eltrombopag) for oral suspensionInitial U.S. Approval:
![These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S. These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=promacta-spl-graphic-16.jpg&id=721800)
These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S.
![Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA](https://www.fda.gov/files/styles/recall_image_small/public/Image%202_2.jpg?itok=NBaoEU5W)
Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA
![Revolade 50 mg (Eltrombopag Olamine) - MBA Pharmaceuticals Pvt Ltd - Pharmaceutical Wholesaler & Exporter Revolade 50 mg (Eltrombopag Olamine) - MBA Pharmaceuticals Pvt Ltd - Pharmaceutical Wholesaler & Exporter](https://www.mbapharmaceuticals.com/wp-content/uploads/2020/01/Revolade_Web.jpg)